Once millions used it to find out about their family histories - this week it was almost delisted. What went wrong?

Andre Fernandez, Jim Frankola and Mark Jensen will join the company's CEO Anne Wojcicki on the board. 23andMe appointed three ...

In September, the company parted ways with all board members with the exception of CEO Anne Wojcicki ... activists from the Electronic Frontier Foundation (EFF) have summarized in a blog post ...

"We're really at a point in time where I'm ready to explode," 23andMe CEO Anne Wojcicki told CNBC in 2021. "There's huge opportunities in therapeutics and huge opportunities in our consumer business." ...

Please keep checking the Foundation programme NHS website for timelines / deadlines. The application window for the 2025 Foundation Programme will open 25 September 2024 and will close 09 October 2024 ...

It's at risk of being delisted from the Nasdaq. Every independent board member has signed leaving only the founder CEO and Anne Wojcicki last year, the company had a massive data breach that ...

With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to ...

Anne Wojcicki, Eren Bali, Jay Desai, Nish Bhat, Matt Mochary, and others. To learn more, visit ambiencehealthcare.com. KLAS is a research and insights firm on a global mission to improve ...

2006: 23andMe is founded in Silicon Valley 23andMe CEO Anne Wojcicki co-founded the company ... The director of cybersecurity at Electronic Frontier Foundation, a nonprofit focused on digital ...

2006: 23andMe is founded in Silicon Valley 23andMe CEO Anne Wojcicki co-founded the company in 2006 with biologist Linda Avey and Paul Cusenza, who previously worked at the now-defunct Perlegen ...

DNA and genetic testing firm 23andMe is in turmoil following a data breach last year and its ongoing financial decline. The ...